Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling plus triamcinolone versus microneedling plus placebo for postoperative scars
IRCT20231222060490N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of triamcinolone in surgical scar (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Vancouver Scar Scale and Visual Analog Scale. Started Dec 2023; status: completed.
02
Drugs
triamcinolone
03
Conditions
surgical scar
Beyond the preview
Go deeper on IRCT20231222060490N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231222060490N1.